Ads
related to: gene therapy
Search results
Taysha Gene Therapies Inc [TSHA] stock for 163,000 USD was acquired by Manning Paul B – Knox Daily
Knox Daily· 7 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Taysha Gene Therapies Inc shares valued at $163,000 were purchased ...
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
Morningstar· 9 hours agoHOUSTON, April 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics") and Charles River Laboratories (“Charles River”), a highly respected, global provider of drug ...
... to Present New Data on its Wholly Owned Gene Therapy Programs in Genetic Epilepsy and...
Napa Valley Register· 3 days agoCompany unveils Parkinson's disease associated with GBA mutations (PD-GBA) program; two oral presentations feature new data from Capsida's wholly owned programs in PD-GBA and genetic epilepsy due to STXBP1 mutations;
Boy with rare blood disorder receives new life-changing gene therapy treatment
WNYW via Yahoo News· 7 days agoYusuf Saeed, an 8-year-old born with a rare genetic blood disorder called thalassemia, received a...
Valley Stream boy, 8, is first in New York State to receive new therapy for blood disorder
Newsday· 6 days agoYusef Saeed, of Valley Stream, received on Jan. 9 an infusion of Zynteglo gene therapy at Cohen...
Long Island boy with rare blood disorder undergoes gene therapy
WPIX 11 New York· 7 days agoLONG ISLAND, N.Y. (PIX11) — Until now, the best treatment for some diseases has been bone marrow...
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
Morningstar· 24 hours ago-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoLeiden, The Netherlands, 19 April 2024 – Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including ...
Earnings call: BioMarin reports solid Q1 growth, plans strategic updates By Investing.com
Investing.com· 5 hours agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced strong first-quarter financials and strategic...
Long Island boy with rare blood disorder undergoes gene therapy
WPIX New York City, NY via Yahoo News· 7 days agoLONG ISLAND, N.Y. (PIX11) — Until now, the best treatment for some diseases has been bone marrow...